Crossref
On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce
Nuclear Medicine Review · 2012
DOI: 10.5603/nmr-18738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Medicine Review, 2012. Verfasst von Dariusz Korecki.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Korecki, D. (2012). On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce. Nuclear Medicine Review. https://doi.org/10.5603/nmr-18738
Vancouver
Korecki D. On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce. Nuclear Medicine Review. 2012. doi:10.5603/nmr-18738
BibTeX
@article{Korecki2012,
author = {Korecki, Dariusz},
title = {On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce},
journal = {Nuclear Medicine Review},
year = {2012},
doi = {10.5603/nmr-18738}
}
EUVIMED